Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06055920 · ClinicalTrials.gov registry record · NA

The PEERLESS II Study

A NA study of Pulmonary Embolism, sponsored by Inari Medical.

Recruiting
Registry status
NA
Development phase
1,200
Enrollment target
20
Study locations

NCT06055920 is a NA study of Pulmonary Embolism that is actively recruiting participants, run by Inari Medical. The registered enrollment target is 1,200 participants, below the 3,033-participant average among 48 other Pulmonary Embolism trials with a reported enrollment target (60% lower). The trial reports 20 study locations across 14 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06055920, a NA study of Pulmonary Embolism, is actively recruiting participants, sponsored by Inari Medical.

RECRUITING
Registry status
NA
Development phase
1,200 participants
Enrollment target
20
Study locations

Study Summary

This study is a prospective, multicenter, randomized controlled trial of the FlowTriever System plus anticoagulation compared to anticoagulation alone for intermediate-risk acute PE.

Conditions Studied

Pulmonary Embolism

Interventions

  • DEVICE FlowTriever System
  • DRUG Anticoagulation Agents

Study Locations (20)

Alabama

  • UAB Division of Cardiovascular Disease - Birmingham
  • Brookwood Medical Center - Birmingham

Florida

  • HCA FL Largo Medical Center - Largo
  • AdventHealth Orlando - Orlando

Minnesota

  • Metropolitan Heart & Vascular Institute - Coon Rapids
  • Mayo Clinic - Rochester

Missouri

  • Saint Luke's Hospital of Kansas City - Kansas City
  • Mercy Hospital Springfield - Springfield

New Jersey

  • Virtua Health - Camden
  • Valley Health - Ridgewood

New York

  • SUNY, The University of Buffalo/Gates Vascular - Buffalo
  • Northwell Health - New York

California

  • Huntington Memorial Hospital - Pasadena

Colorado

  • University of Colorado, Denver - Aurora

Trial Details

FieldValue
Enrollment Target 1,200 participants
Start Date 2023-11-17
Est. Completion 2026-07
Phase NA

Sponsor

Inari Medical

12 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT06055920

The ClinicalTrials.gov registry entry for NCT06055920 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 1,200 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 3,033-participant average among 48 other Pulmonary Embolism trials with a reported enrollment target (60% lower). The listed sponsor is Inari Medical, which has 12 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Pulmonary Embolism appearing as the primary indexed condition, and to 2 interventions - of which FlowTriever System is the first listed.

NCT06055920 reports 20 study locations spanning 14 distinct geographic areas - top geographies include Alabama, Florida, Minnesota.

Frequently Asked Questions

What is clinical trial NCT06055920 about?

NCT06055920 is a clinical study titled "The PEERLESS II Study". This study is a prospective, multicenter, randomized controlled trial of the FlowTriever System plus anticoagulation compared to anticoagulation alone for intermediate-risk acute PE.

What is the current status of trial NCT06055920?

This trial is currently recruiting. It is a NA study. The enrollment target is 1,200 participants. The study started on 2023-11-17. Estimated completion is 2026-07.

What conditions does trial NCT06055920 study?

This clinical trial studies the following conditions: Pulmonary Embolism.

What interventions are being tested in trial NCT06055920?

The interventions under investigation include: FlowTriever System (DEVICE), Anticoagulation Agents (DRUG).

Who is sponsoring clinical trial NCT06055920?

This trial is sponsored by Inari Medical, which has 12 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06055920 being conducted?

This trial has 20 study locations across Alabama, California, Colorado, Connecticut, Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Pulmonary Embolism

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Pulmonary Embolism

All registered trials for this condition

Alabama

All trials with a study site in Alabama

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.